All of the measured components within the score, impaired GLS (18), elevated NT-proBNP (19), and E/A ratio (20) have been associated with adverse outcomes in patients with type 2 diabetes without prior history of MI. This evidence concerns the gene NPPB and type 2 diabetes mellitus.